Article
Structural Studies of Inhibitors with Clinically Relevant Influenza Endonuclease Variants
8 Jan 2024
Abstract excerpt
High Resolution Image Download MS PowerPoint Slide Vital to the treatment of influenza is the use of antivirals such as Oseltamivir (Tamiflu) and Zanamivir (Relenza); however, antiviral resistance is becoming an increasing problem for these therapeutics. The RNA-dependent RNA polymerase acidic N-terminal (PA N ) endonuclease, a critical component of influenza viral replication machinery, is an antiviral target...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
